Abbonarsi

Caffeinated coffee consumption and mortality after acute myocardial infarction - 26/08/11

Doi : 10.1016/j.ahj.2003.12.038 
Kenneth J Mukamal, MD, MPH, MA a, , Malcolm Maclure, ScD b, James E Muller, MD c, Jane B Sherwood, RN d, Murray A Mittleman, MD, DrPH b, e
a Divisions of General Medicine and Primary Care, Boston, Mass, USA 
e Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass, USA 
b Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA 
c Division of Cardiology, Massachusetts General Hospital, Boston, Mass, USA 
d Department of Health and Social Behavior, Harvard School of Public Health, Boston, Mass., USA 

*Reprint requests: Kenneth J. Mukamal, MD, MPH, MA, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, 330 Brookline Ave, RO-114, Boston, MA 02215, USA.

Abstract

Background

Previous studies have generally suggested no effect of coffee consumption on the risk of acute myocardial infarction. The effect of coffee consumption on prognosis after acute myocardial infarction is uncertain.

Methods

In an inception cohort study, we observed 1935 patients who were hospitalized with a confirmed acute myocardial infarction between 1989 and 1994 at 45 community hospitals and tertiary care centers in the United States, as part of the Determinants of Myocardial Infarction Onset Study. Trained interviewers assessed self-reported caffeinated coffee consumption before infarction with a standardized questionnaire. We analyzed survival censored at December 31, 1995, using Cox proportional hazards regression.

Results

Of the 1902 patients for whom we had information on coffee intake, 315 (17%) died during a median follow-up period of 3.8 years. Coffee drinkers tended to be men, younger, and free of comorbidity, and they were more likely to be current smokers. Coffee consumption was not associated with an overall change in long-term post-infarction mortality rate. However, we did observe an unexpected and unexplained variation in the association between coffee consumption and mortality with time, with an apparent inverse association in the first 90 days after infarction.

Conclusions

Self-reported coffee consumption has no overall association with post-infarction mortality. The unexpected time variation in the effect of coffee intake requires evaluation in other studies.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Supported by grants from the American Heart Association, Dallas, Tex (9630115N), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md (K23AA00299) and National Heart, Lung, and Blood Institute, Bethesda, Md (R01HL41016).


© 2004  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 6

P. 999-1004 - Giugno 2004 Ritorno al numero
Articolo precedente Articolo precedente
  • Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the assessment of the safety of a new thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction
  • Peter R Sinnaeve, John H Alexander, Kris Bogaerts, Ann Belmans, Lars Wallentin, Paul Armstrong, Jennifer A.A Adgey, Michal Tendera, Rafael Diaz, Leopoldo Soares-Piegas, Alec Vahanian, Christopher B Granger, Frans J Van De Werf
| Articolo seguente Articolo seguente
  • Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels
  • Efthymios N Deliargyris, Phoebus N Madianos, Waka Kadoma, Irene Marron, Sidney C Smith, James D Beck, Steven Offenbacher

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.